From: Pharmacologic Therapy for Type 2 Diabetes Mellitus Ann Intern Med. 1999;131(4):281-303. doi:10.7326/0003-4819-131-4-199908170-00008 Figure Legend: Pathogenesis of type 2 diabetes mellitus. Date of download: 10/20/2017 Copyright © American College of Physicians. All rights reserved.
From: Pharmacologic Therapy for Type 2 Diabetes Mellitus Ann Intern Med. 1999;131(4):281-303. doi:10.7326/0003-4819-131-4-199908170-00008 Figure Legend: Time-related change in median fasting plasma glucose level (left) and median hemoglobin A(HbA) (right) in patients with type 2 diabetes treated with sulfonylureas (triangles), metformin (diamonds), insulin (squares), or conventional (diet) therapy (circles). Date of download: 10/20/2017 Copyright © American College of Physicians. All rights reserved.
From: Pharmacologic Therapy for Type 2 Diabetes Mellitus Ann Intern Med. 1999;131(4):281-303. doi:10.7326/0003-4819-131-4-199908170-00008 Figure Legend: Effect of conventional treatment with diet (bold solid line), intensive treatment with sulfonylureas or insulin (solid line), and metformin therapy (dashed line) on any diabetes-related end point (top left), diabetes-related death (bottom left), microvascular complications (top right), and myocardial infarction (bottom right).P Date of download: 10/20/2017 Copyright © American College of Physicians. All rights reserved.
From: Pharmacologic Therapy for Type 2 Diabetes Mellitus Ann Intern Med. 1999;131(4):281-303. doi:10.7326/0003-4819-131-4-199908170-00008 Figure Legend: Pharmacologic algorithm for treatment of patients in whom type 2 diabetes is inadequately controlled with diet and exercise. Date of download: 10/20/2017 Copyright © American College of Physicians. All rights reserved.